Markets:

Overview

News

Currencies

International

Treasuries

CVS Health Corp (NY:CVS)

78.47 +0.57 (+0.73%)

Official Closing Price Updated: 7:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

63 64 Next >

Is Walgreens Boots Alliance a Millionaire Maker? ↗

December 15, 2024

The company could soon start growing earnings again, offering investors an 11% dividend yield.

Via The Motley Fool

Joe Rogan On Public Sympathy For UnitedHealthcare CEO Murder Suspect: Health Insurance A 'Dirty, Dirty Business' ↗

December 12, 2024

Joe Rogan stopped short of offering any sympathy for the death of UnitedHealthcare CEO Brian Thompson with criticism of the health insurance sector.

Via Benzinga

Stock Of The Day: Historic Technical Analysis Lesson In CVS ↗

December 12, 2024

'Market Memory' means that important price levels can stay intact for weeks, months, or even years. The chart of CVS proves this.

Via Benzinga

CVS Health Hits 11-Year Low; PBM Legislation Could Slash Earnings By 50%, Says Analyst ↗

December 12, 2024

New bipartisan legislation targets pharmacy benefit managers.

Via Investor's Business Daily

Bipartisan Lawmakers Aim To Break Up Health Care Giants With New Legislation ↗

December 11, 2024

Pharmacy-benefit managers (PBMs) have been scrutinized for their role in drug distribution for years. Now a bipartisan group of lawmakers is threatening to break up the companies behind these so-called...

Via Benzinga

Why UnitedHealth Group Stock Was Falling Today ↗

December 11, 2024

Via The Motley Fool

What the Options Market Tells Us About CVS Health ↗

December 11, 2024

Via Benzinga

Key Takeaways From CVS Health Analyst Ratings ↗

December 03, 2024

Via Benzinga

Is CVS Health Stock a Buy? ↗

December 02, 2024

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

December 11, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 10, 2024

Via Benzinga

What’s Behind These 3 Recent Analyst Stock Upgrades?

December 08, 2024

Three recent analyst ratings go beyond the consensus, making them a much more significant move for Wall Street analysts to consider.

Via MarketBeat

Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 7 ↗

December 07, 2024

What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Dec. 2-6, 2024.

Via Talk Markets

Topics Stocks / Equities

CVS Health's Options: A Look at What the Big Money is Thinking ↗

November 29, 2024

Via Benzinga

(CVS) - Analyzing CVS Health's Short Interest ↗

November 21, 2024

Via Benzinga

Is CVS Health Stock an Underrated Buy? ↗

November 20, 2024

Via The Motley Fool

Blue Shield's $500 Million Drug Savings Initiative With Amazon Pharmacy Can Potentially Launch In January ↗

December 06, 2024

Blue Shield of California launches its Pharmacy Care Reimagined Initiative with Amazon Pharmacy and Abarca in January, aiming to save $500 million annually in drug costs.

Via Benzinga

UnitedHealthcare Faces Scrutiny Amid CEO's Tragic Death, Industry Criticism ↗

December 06, 2024

UnitedHealthcare's claim denial practices are under scrutiny following the murder of CEO Brian Thompson, with criticism over its profit-driven approach to care.

Via Benzinga

13 Healthcare Sector Stocks With Healthy Valuation ↗

December 05, 2024

We are looking for value in the Healthcare Sector because we are still in a strong bull market that has been not only one of the longest on record, but also has seen the S&P 500 get to one of its lofty...

Via Talk Markets

Topics Stocks Stocks / Equities

The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market ↗

December 05, 2024

An age-old battle in pharmaceuticals could further rattle Eli Lilly stock and its potential $100 billion market in obesity.

Via Investor's Business Daily

This Citigroup Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

December 03, 2024

Via Benzinga

CVS Health Options Trading: A Deep Dive into Market Sentiment ↗

November 19, 2024

Via Benzinga

Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA? ↗

November 28, 2024

As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector.

Via Benzinga

Topics Cannabis

3 Key Analyst Upgrades: Why These Stocks Are Getting a Boost

November 26, 2024

Retail investors have a chance to break down the reasons behind the latest analyst upgrades and why they're being made in these three stocks.

Via MarketBeat

Topics Economy

Billionaire Israel Englander Bought This High-Yield Dividend Stock Hand Over Fist in Q3. Should You Buy It Too? ↗

November 25, 2024

Via The Motley Fool

Palantir Price Target Raised To $75 By Dan Ives Amid 288% YTD Surge: Analyst Calls 2025 A 'Primetime' Year For AI ↗

November 24, 2024

Wedbush Securities has issued an endorsement of the artificial intelligence software sector, with Managing Director Dan Ives predicting that 2025 will be a pivotal year for AI implementation across the...

Via Benzinga

Topics Artificial Intelligence

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields ↗

November 21, 2024

Via Benzinga

Mohamed El-Erian Warns Against Simplistic Narratives As Trump Plans Aggressive Tariff Strategy: 'The Issue Is Quite Complex' ↗

November 21, 2024

As President-elect Donald Trump prepares to return to the White House, renowned economist Mohamed El-Erian is cautioning against media oversimplification of the incoming administration's proposed...

Via Benzinga

Topics Government World Trade

Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System ↗

November 20, 2024

PBMs Express Scripts, Caremark, and Optum challenge the FTC's administrative proceedings, arguing it violates constitutional rights and threatens the stability of drug pricing.

Via Benzinga

1 Great Reason to Buy Realty Income and Hold It Forever ↗

November 20, 2024

Via The Motley Fool

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

63 64 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

CVS Health Corp (NY:CVS)

All News about CVS Health Corp

Starting at $3.75/week.

Subscribe Today